Experiment: 7FHQ

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	10 % v/v [U-100% 2H] D2O, 90 % v/v H2O, 20 mM sodium acetate, 0.02 % w/v sodium azide, 0.65 mM [U-99% 15N] HuPrP G131V	90% H2O/10% D2O	20 mM	4.5	1 atm	298	Bruker AVANCE III 850
2	2D 1H-13C HSQC	10 % v/v [U-100% 2H] D2O, 90 % v/v H2O, 20 mM sodium acetate, 0.02 % w/v sodium azide, 0.65 mM [U-99% 13C; U-99% 15N] HuPrP G131V	90% H2O/10% D2O	20 mM	4.5	1 atm	298	Bruker AVANCE III 850
11	2D (HB)CB(CGCD)HD	10 % v/v [U-100% 2H] D2O, 90 % v/v H2O, 20 mM sodium acetate, 0.02 % w/v sodium azide, 0.65 mM [U-99% 13C; U-99% 15N] HuPrP G131V	90% H2O/10% D2O	20 mM	4.5	1 atm	298	Bruker AVANCE III 850
12	2D (HB)CB(CGCDCE)HE	10 % v/v [U-100% 2H] D2O, 90 % v/v H2O, 20 mM sodium acetate, 0.02 % w/v sodium azide, 0.65 mM [U-99% 13C; U-99% 15N] HuPrP G131V	90% H2O/10% D2O	20 mM	4.5	1 atm	298	Bruker AVANCE III 850
3	3D HNCACB	10 % v/v [U-100% 2H] D2O, 90 % v/v H2O, 20 mM sodium acetate, 0.02 % w/v sodium azide, 0.65 mM [U-99% 13C; U-99% 15N] HuPrP G131V	90% H2O/10% D2O	20 mM	4.5	1 atm	298	Bruker AVANCE III 850
4	3D CBCA(CO)NH	10 % v/v [U-100% 2H] D2O, 90 % v/v H2O, 20 mM sodium acetate, 0.02 % w/v sodium azide, 0.65 mM [U-99% 13C; U-99% 15N] HuPrP G131V	90% H2O/10% D2O	20 mM	4.5	1 atm	298	Bruker AVANCE III 850
5	3D HNCA	10 % v/v [U-100% 2H] D2O, 90 % v/v H2O, 20 mM sodium acetate, 0.02 % w/v sodium azide, 0.65 mM [U-99% 13C; U-99% 15N] HuPrP G131V	90% H2O/10% D2O	20 mM	4.5	1 atm	298	Bruker AVANCE III 850
6	3D HN(CO)CA	10 % v/v [U-100% 2H] D2O, 90 % v/v H2O, 20 mM sodium acetate, 0.02 % w/v sodium azide, 0.65 mM [U-99% 13C; U-99% 15N] HuPrP G131V	90% H2O/10% D2O	20 mM	4.5	1 atm	298	Bruker AVANCE III 850
7	3D HNCO	10 % v/v [U-100% 2H] D2O, 90 % v/v H2O, 20 mM sodium acetate, 0.02 % w/v sodium azide, 0.65 mM [U-99% 13C; U-99% 15N] HuPrP G131V	90% H2O/10% D2O	20 mM	4.5	1 atm	298	Bruker AVANCE III 850
8	3D HN(CA)CO	10 % v/v [U-100% 2H] D2O, 90 % v/v H2O, 20 mM sodium acetate, 0.02 % w/v sodium azide, 0.65 mM [U-99% 13C; U-99% 15N] HuPrP G131V	90% H2O/10% D2O	20 mM	4.5	1 atm	298	Bruker AVANCE III 850
15	3D HBHA(CO)NH	10 % v/v [U-100% 2H] D2O, 90 % v/v H2O, 20 mM sodium acetate, 0.02 % w/v sodium azide, 0.65 mM [U-99% 13C; U-99% 15N] HuPrP G131V	90% H2O/10% D2O	20 mM	4.5	1 atm	298	Bruker AVANCE III 850
16	3D H(CCO)NH	10 % v/v [U-100% 2H] D2O, 90 % v/v H2O, 20 mM sodium acetate, 0.02 % w/v sodium azide, 0.65 mM [U-99% 13C; U-99% 15N] HuPrP G131V	90% H2O/10% D2O	20 mM	4.5	1 atm	298	Bruker AVANCE III 850
9	3D HCCH-TOCSY	10 % v/v [U-100% 2H] D2O, 90 % v/v H2O, 20 mM sodium acetate, 0.02 % w/v sodium azide, 0.65 mM [U-99% 13C; U-99% 15N] HuPrP G131V	90% H2O/10% D2O	20 mM	4.5	1 atm	298	Bruker AVANCE III 850
14	3D C(CO)NH	10 % v/v [U-100% 2H] D2O, 90 % v/v H2O, 20 mM sodium acetate, 0.02 % w/v sodium azide, 0.65 mM [U-99% 13C; U-99% 15N] HuPrP G131V	90% H2O/10% D2O	20 mM	4.5	1 atm	298	Bruker AVANCE III 850
13	3D 1H-15N TOCSY	10 % v/v [U-100% 2H] D2O, 90 % v/v H2O, 20 mM sodium acetate, 0.02 % w/v sodium azide, 0.65 mM [U-99% 13C; U-99% 15N] HuPrP G131V	90% H2O/10% D2O	20 mM	4.5	1 atm	298	Bruker AVANCE III 850
10	3D HCCH-TOCSY	10 % v/v [U-100% 2H] D2O, 90 % v/v H2O, 20 mM sodium acetate, 0.02 % w/v sodium azide, 0.65 mM [U-99% 13C; U-99% 15N] HuPrP G131V	90% H2O/10% D2O	20 mM	4.5	1 atm	298	Bruker AVANCE III 850
18	3D 1H-15N NOESY	10 % v/v [U-100% 2H] D2O, 90 % v/v H2O, 20 mM sodium acetate, 0.02 % w/v sodium azide, 0.65 mM [U-99% 15N] HuPrP G131V	90% H2O/10% D2O	20 mM	4.5	1 atm	298	Bruker AVANCE III 850
17	3D 1H-13C NOESY	100 % v/v [U-100% 2H] D2O, 20 mM sodium acetate, 0.02 % w/v sodium azide, 0.65 mM [U-99% 13C; U-99% 15N] HuPrP G131V	100% D2O	20 mM	4.5	1 atm	298	Bruker AVANCE III 850

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	850

NMR Refinement
Method	Details	Software
simulated annealing		CNS

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	200
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
2	chemical shift assignment	NMRFAM-SPARKY	1.4.7	Lee W., Tonelli M., Markley J. L.
3	structure calculation	CNS	Aria2.3	Brunger, Adams, Clore, Gros, Nilges and Read
4	refinement	CNS	Aria2.3	Brunger, Adams, Clore, Gros, Nilges and Read

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.